Seasoned executive in global healthcare and IVD markets
He is seasoned executive in global healthcare and IVD markets, instrumental in the transformation of the business. He led the group through four acquisitions including Elucigene Diagnostics and Coastal Genomics and the fundraising to underpin those deals. Under his leadership he has grown the business from £30million to greater than £100 million market cap.
See also: Yourgene Health - Molecular diagnostics group which develops and commercialises genetic products and services to positively impact human health
Lyn Rees News
Contract award for the supply of DPYD testing kits to NHS Wales
GenomeWeb - 18-Jun-2021
Technology suitable for meeting the lab requirements to deliver the serviceRead more...